Tredje AP-fonden’s Charles River Laboratories CRL Stock Holding History

Tredje AP-fonden’s Portfolio CRL Stock Details CRL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-3,996	Closed	-$601K	–	387
2025 Q1	$601K	Hold	3,996	–	–	0.01%	409
2024 Q4	$738K	Sell	3,996 -3,996	-50%	-$770K	0.01%	441
2024 Q3	$1.57M	Hold	7,992	–	–	0.01%	406
2024 Q2	$1.65M	Sell	7,992 -126	-2%	-$28.6K	0.02%	384
2024 Q1	$2.2M	Hold	8,118	–	–	0.02%	344
2023 Q4	$1.92M	Sell	8,118 -330	-4%	-$64.9K	0.02%	389
2023 Q3	$1.66M	Sell	8,448 -790	-9%	-$162K	0.02%	407
2023 Q2	$1.94M	Sell	9,238 -1,550	-14%	-$308K	0.03%	388
2023 Q1	$2.18M	Buy	10,788 +505	+5%	+$114K	0.03%	374
2022 Q4	$2.24M	Sell	10,283 -3,468	-25%	-$757K	0.04%	350
2022 Q3	$2.71M	Buy	13,751 +10,371	+307%	+$2.24M	0.06%	261
2022 Q2	$723K	Hold	3,380	–	–	0.02%	310
2022 Q1	$960K	Hold	3,380	–	–	0.02%	318
2021 Q4	$1.27M	Buy	+3,380	New	+$1.31M	0.02%	316

Other funds holding CRL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return

Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Tredje AP-fonden's CRL Position: Q2 2025 in Review

Tredje AP-fonden sold out of Charles River Laboratories (CRL) in Q2 2025, closing a stake of 3,996 shares — an estimated $601K sold.

Tredje AP-fonden first reported a position in CRL in Q4 2021 and held it in 14 quarters. The position peaked at $2.71M in Q3 2022. 518 funds tracked by Wall St. Rank hold CRL as of Q2 2025.

Tredje AP-fonden reported no remaining Charles River Laboratories position as of Q2 2025 after selling out during the quarter.
Tredje AP-fonden sold 3,996 Charles River Laboratories shares in Q2 2025, an estimated $601K.
Tredje AP-fonden first reported a position in Charles River Laboratories in Q4 2021 and held it in 14 quarters.
Tredje AP-fonden's Charles River Laboratories position peaked at $2.71M in Q3 2022.
518 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2025.

Based on Tredje AP-fonden's 13F filing for Q2 2025, filed 5 Aug 2025.